The hallmark genetic abnormality of CML is a t(9;22)(q34;q11) translocation in a ‘Philadelphia chromosome,’ containing a breakpoint cluster region (BCR) sequence, and chromosome 9, containing Abelson proto-oncogene (ABL) sequence. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.